US Patent Issued to Boehringer Ingelheim International on Dec. 16 for "Substituted tetrazoles as TRPA1 inhibitors" (German Inventors)

ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,497,401, issued on Dec. 16, was assigned to Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany).

"Substituted tetrazoles as TRPA1 inhibitors" was invented by Martin Thomas Fleck (Munich), Florian Paul Christian Binder (Maselheim, Germany), Georg Dahmann (Biberach, Germany), Joerg P. Hehn (Biberach an der Riss, Germany), Uta Friederike Lessel (Maselheim, Germany) and Jens Willwacher (Biberach an der Riss, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention related to substituted tetrazoles and their use as inhibitors of TRPA1 activity, pharmaceutical compositions containing the same, and methods of using the same as ag...